Letter in response to 'Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors'

Affiliations

¹ Department of Medicine, McGill University, Canada; Division of Rheumatology, Jewish General Hospital, Montreal, Canada. Electronic address: valerie.leclair@ki.se.
² Department of Medicine, Université de Montréal, Canada; Division of Rheumatology, Centre Hospitalier Universitaire de Montréal, Montreal, Canada.
³ Department of Medicine, McGill University, Canada; Division of Rheumatology, Jewish General Hospital, Montreal, Canada; Lady Davis Institute, Montreal, Quebec, Canada.

Comment

Valérie Leclair et al. Eur J Cancer. 2019 May.

. 2019 May:112:47-48.

doi: 10.1016/j.ejca.2019.02.010. Epub 2019 Mar 23.

¹ Department of Medicine, McGill University, Canada; Division of Rheumatology, Jewish General Hospital, Montreal, Canada. Electronic address: valerie.leclair@ki.se.
² Department of Medicine, Université de Montréal, Canada; Division of Rheumatology, Centre Hospitalier Universitaire de Montréal, Montreal, Canada.
³ Department of Medicine, McGill University, Canada; Division of Rheumatology, Jewish General Hospital, Montreal, Canada; Lady Davis Institute, Montreal, Quebec, Canada.

No abstract available

Comment on

Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors.
Moreira A, Loquai C, Pföhler C, Kähler KC, Knauss S, Heppt MV, Gutzmer R, Dimitriou F, Meier F, Mitzel-Rink H, Schuler G, Terheyden P, Thoms KM, Türk M, Dummer R, Zimmer L, Schröder R, Heinzerling L. Moreira A, et al. Eur J Cancer. 2019 Jan;106:12-23. doi: 10.1016/j.ejca.2018.09.033. Epub 2018 Nov 17. Eur J Cancer. 2019. PMID: 30453170